A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity

Abstract This study aimed to find the association between four common clinical biomarkers and subsequent ICICT, developing a risk scoring strategy to assess the ICICT risk. Three terminals for ICICT were : Terminal 1, cancer therapy-related cardiomyopathies; Terminal 2, myocarditis or heart failure;...

Cijeli opis

Bibliografski detalji

Glavni autori:	Zhulu Chen, Rui Lan, Tao Ran, Li Tao, Yuxi Zhu, Yanwei Li, Chuan Zhang, Min Mao, Diansa Gao, Zhong Zuo
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2024-10-01
Serija:	Scientific Reports
Teme:	Immune checkpoint inhibitors Cardiotoxicity Multimodality score strategy Cardio-oncology Biomarkers
Online pristup:	https://doi.org/10.1038/s41598-024-76829-5
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!